Atlas FDA

ALIZEA SR/DR and CELEA SR/DR 1.5T and 3T Full Body MRI conditional pacemakers

FDA premarket approval P950029/S127 · decided 2023-05-17

Approval details

PMA number
P950029
Supplement
S127
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
ALIZEA SR/DR and CELEA SR/DR 1.5T and 3T Full Body MRI conditional pacemakers
Generic name
implantable pacemaker Pulse-generator
Applicant
MicroPort CRM USA, Inc.
Date received
2020-08-10
Decision date
2023-05-17
Days to decision
1010 days
Decision code
APPR
Product code
DXY
Advisory committee
Cardiovascular
Expedited review
No
Location
Arlington, TN
Statement
Approval for ALIZEA and CELEA pacemakers.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.